Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients

Introduction: Immunosuppression after pediatric liver transplantation remains a major challenge. MTOR inhibitors provide a promising therapeutic approach in combination with reduced CNI after transplantation. However, there are still few data regarding their use in children. Patients: We analyzed 37...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehming, Mathis, Krebs-Schmitt, Dorothée, Briem-Richter, Andrea, Hegen, Bianca, Brinkert, Florian, Fischer, Lutz, Grabhorn, Enke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955171/
https://www.ncbi.nlm.nih.gov/pubmed/36832496
http://dx.doi.org/10.3390/children10020367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955171/
https://www.ncbi.nlm.nih.gov/pubmed/36832496
http://dx.doi.org/10.3390/children10020367

Ejemplares similares